LRP-1 ligand internalization functions were later exploited and found to very efficiently enable a 19 amino acid brain-penetrant peptide, named Angiopep-2 (An2), to cross the BBTB and to target the brain cancer cell compartment [18,19]. This evidence concerns the gene LRP1 and brain cancer.